E-resources
Peer reviewed
-
Hill, Helen; Mitsi, Elena; Nikolaou, Elissavet; Blizard, Annie; Pojar, Sherin; Howard, Ashleigh; Hyder-Wright, Angela; Devin, Jack; Reiné, Jesus; Robinson, Ryan; Solórzano, Carla; Jochems, Simon P; Kenny-Nyazika, Tinashe; Ramos-Sevillano, Elisa; Weight, Caroline M; Myerscough, Chris; McLenaghan, Daniella; Morton, Ben; Gibbons, Emily; Farrar, Madlen; Randles, Victoria; Burhan, Hassan; Chen, Tao; Shandling, Adam D; Campo, Joe J; Heyderman, Robert S; Gordon, Stephen B; Brown, Jeremy S; Collins, Andrea M; Ferreira, Daniela M
American journal of respiratory and critical care medicine, 2023-Oct-15, Volume: 208, Issue: 8Journal Article
Pneumococcal pneumonia remains a global health problem. Pneumococcal colonization increases local and systemic protective immunity, suggesting that nasal administration of live attenuated (Spn) strains could help prevent infections. We used a controlled human infection model to investigate whether nasopharyngeal colonization with attenuated strains protected against recolonization with wild-type (WT) Spn (SpnWT). Healthy adults aged 18-50 years were randomized (1:1:1:1) for nasal administration twice (at a 2-wk interval) with saline solution, WT Spn6B (BHN418), or one of two genetically modified Spn6B strains, SpnA1 ( ) or SpnA3 ( ) (Stage I). After 6 months, participants were challenged with SpnWT to assess protection against the homologous serotype (Stage II). 125 participants completed both study stages per intention to treat. No serious adverse events were reported. In Stage I, colonization rates were similar among groups: SpnWT, 58.1% (18 of 31); SpnA1, 60% (18 of 30); and SpnA3, 59.4% (19 of 32). Anti-Spn nasal IgG levels after colonization were similar in all groups, whereas serum IgG responses were higher in the SpnWT and SpnA1 groups than in the SpnA3 group. In colonized individuals, increases in IgG responses were identified against 197 Spn protein antigens and serotype 6 capsular polysaccharide using a pangenome array. Participants given SpnWT or SpnA1 in Stage I were partially protected against homologous challenge with SpnWT (29% and 30% recolonization rates, respectively) at stage II, whereas those exposed to SpnA3 achieved a recolonization rate similar to that in the control group (50% vs. 47%, respectively). Nasal colonization with genetically modified live attenuated Spn was safe and induced protection against recolonization, suggesting that nasal administration of live attenuated Spn could be an effective strategy for preventing pneumococcal infections. Clinical trial registered with the ISRCTN registry (ISRCTN22467293).
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.